Alkem Laboratories Ltd (ALKEM)

Alkem Laboratories Rebrands API Business as Alkem Activa - 21 Sep, 2023

Alkem Laboratories Ltd has rebranded its active pharmaceutical ingredients (API) business as Alkem Activa. The company aims to produce high-quality APIs and expand capacity with advanced technologies to become a reliable supplier of quality APIs worldwide.

Alkem Labs Appoints New CEO Amidst Income Tax Survey - 15 Sep, 2023

Shares of Alkem Laboratories Ltd fell nearly 2% after the income tax department conducted a survey at some of its offices and subsidiaries. The company is fully cooperating with officials. Additionally, the board appointed Dr. Vikas Gupta as CEO effective September 22, 2023.

IT Survey Conducted at Alkem Labs Offices - 14 Sep, 2023

The Income Tax Department conducted a survey at multiple offices and subsidiaries of Alkem Laboratories Ltd. The company is fully cooperating with the officials of the IT Department. Additionally, Alkem Laboratories has low net debt.

Alkem Laboratories among stocks with long build-up - 12 Sep, 2023

According to recent reports, Alkem Laboratories is one of the stocks that experienced a long build-up.

Alkem Laboratories Stock Slips 0.45% - 09 Sep, 2023

Shares of Alkem Laboratories Limited closed at Rs 3,621.25 on Friday, slipping around 0.45% compared to the previous closing levels. The company's stock is currently trading at a discount of approximately 15% from its 52-week high in August 2023.

Alkem Labs Reports Surge in Operating Profit - 24 Aug, 2023

Alkem Laboratories reports surge in operating profit of over 91% YoY, while revenue grew by just 15%. The company also received a decent approval for US growth.

Alkem Labs Stock Falls on Sales Outlook - 17 Aug, 2023

Alkem Laboratories Ltd's stock fell 9% over two days as its FY24 India sales are expected to miss double-digit growth. However, it still presents an opportunity for investors due to the revival of the US generic market.

Alkem Laboratories Delivers Better-Than-Expected 1QFY24 Performance - 16 Aug, 2023

Alkem Laboratories (ALKEM) reported strong growth in international markets, including the US, Chile, the UK, Kazakhstan and the Philippines. However, earnings estimates have been cut for FY24/FY25 due to unfavorable seasonality effects in domestic formulation segment and increased tax rates. Maintain Neutral.

Alkem Laboratories Records Marginal Growth in Indian Pharma Market - 14 Aug, 2023

Alkem Laboratories Ltd recorded a marginal growth of 2.4% YoY in the Indian pharma market in July.

Alkem Labs Shares Fall After Earnings Release - 11 Aug, 2023

Shares of Alkem Laboratories Ltd fell by 9% following the release of its Q1FY24 earnings report, which showed underperformance of domestic business and lowered revenue guidance for FY24.

Alkem Labs Reports Strong Q1 Results and Dividend Announcement - 10 Aug, 2023

Alkem Laboratories Ltd reported strong Q1 results with a YoY surge in PAT by 124.6%, revenue up 15.2%. The company also announced a dividend of ₹7.5 per share. Alkem is one of the 10 stocks exhibiting notable overbought characteristics.

Alkem Laboratories Hits New Highs - 09 Aug, 2023

Alkem Laboratories Ltd's share price hits a new 52-week high of Rs 4,229.40 and has seen a significant increase over the past month.

Alkem Labs Hits All-Time High, LIC Trims Stake - 08 Aug, 2023

Alkem Laboratories Ltd's stock hit an all-time high last week while LIC trimmed its stake worth Rs 886 crore.

Alkem Laboratories to Pay Dividend of Rs 10 per Share - 06 Aug, 2023

Alkem Laboratories Limited will pay a dividend of ₹10.00 per share on September 24th, with an ex-dividend date of August 10th.

Alkem Laboratories Hits New 52-Week High - 03 Aug, 2023

Alkem Laboratories Ltd's stock achieves a significant milestone by hitting a new 52-week high of Rs 4,080.00.

Alkem Laboratories Hits All-Time Highs - 31 Jul, 2023

Alkem Laboratories Ltd's stock hit fresh all-time highs, while also being in an overbought zone with an RSI of 81.86.

Pharma Stocks Rally, Alkem Up 32% - 30 Jul, 2023

Alkem Laboratories Ltd's stock has witnessed a spectacular rally, up 32% YTD, along with other pharma stocks. Cipla and Alkem already have a significant presence in the segment.

Insiders Hold Majority Stake in Alkem Laboratories - 28 Jul, 2023

Top 4 shareholders, including individual insiders and top executives, own 51% of Alkem Laboratories. Samprada & Nanhamati Singh Family Trust is the largest shareholder with a 21% stake. Hedge funds have minimal shares.

Alkem Labs Gains in Realty Sector, LIC Sells Stake - 27 Jul, 2023

Alkem Laboratories Ltd saw gains of around 2% in the realty sector while LIC sold a portion of its stake in the company for ₹936.3 crore during Q1 FY24.

Analysts Caution Against Alkem Laboratories Stock - 21 Jul, 2023

Alkem Laboratories stock has only returned 8.63% over the past three months, compared to Torrent and JB stocks which have delivered 22.24% returns each. Analysts caution against investing in Alkem.